TARA - Protara Therapeutics, Inc.

QQQ $ 459.86 $ 0.43 (0.09 %)

DIA $ 407.95 $ -1.96 (-0.48 %)

SPY $ 548.56 $ -1.34 (-0.24 %)

TLT $ 99.56 $ 0.56 (0.57 %)

GLD $ 232.35 $ 1.92 (0.83 %)

Previous Close

$ 1.9

Open

$ 1.91

Bid

$ 1.92 x 200

Ask

$ 1.94 x 200

Day's Range

$ 1.91 - $ 1.97

52 Week Range

$ 1.04 - $ 5.24

Volume

108,899

Average Volume

Market Cap

39.2M

Beta (5Y Monthly)

$ 1.47

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	03-13-2024	12-31-2023	10-K
4	11-03-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-08-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	03-09-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-11-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	07-31-2020	06-30-2020	10-Q
18	05-13-2020	03-31-2020	10-Q
19	03-20-2020	12-31-2019	10-K
20	10-31-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-08-2019	03-31-2019	10-Q
23	03-13-2019	12-31-2018	10-K
24	11-07-2018	09-30-2018	10-Q
25	08-07-2018	06-30-2018	10-Q
26	05-09-2018	03-31-2018	10-Q
27	03-14-2018	12-31-2017	10-K
28	11-07-2017	09-30-2017	10-Q
29	08-07-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-16-2017	12-31-2016	10-K
32	11-07-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-09-2016	03-31-2016	10-Q
35	03-14-2016	12-31-2015	10-K
36	11-12-2015	09-30-2015	10-Q
37	08-13-2015	06-30-2015	10-Q
38	05-13-2015	03-31-2015	10-Q
39	03-20-2015	12-31-2014	10-K
40	11-25-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oppenheimer Maintains Outperform on Protar...
08/12/2024 13:43:10

Oppenheimer analyst Leland Gershell maintains Protara Therapeutics (NASDAQ:TARA) with a Outperform and lowers the price targ...

HC Wainwright & Co. Reiterates Buy on Prot...
08/08/2024 11:26:29

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price...

Protara Therapeutics Q2 EPS $(0.45) Beats ...
08/06/2024 12:13:02

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of ...

Watching Protara Therapeutics, Opthea Ltd....
05/09/2024 14:24:33

https://blog.tipranks.com/these-2-strong-buy-penny-stocks-could-surge-over-400-says-oppenheimer/

HC Wainwright & Co. Reiterates Buy on Prot...
05/06/2024 10:42:05

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price...

Protara Therapeutics Q1 EPS $(0.97) Misses...
05/02/2024 12:06:22

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate o...

Alphabet To Rally Around 14%? Here Are 10 ...
04/22/2024 12:32:56

Oppenheimer Maintains Outperform on Protar...
04/22/2024 11:21:21

Oppenheimer analyst Leland Gershell maintains Protara Therapeutics (NASDAQ:TARA) with a Outperform and raises the price targ...

HC Wainwright & Co. Maintains Buy on Prota...
04/08/2024 11:15:31

HC Wainwright & Co. analyst Andrew Fein maintains Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price ...

protara-therapeutics-shares-interim-data-from-bladder-cancer-study-raises-45m-via-equity

Protara Therapeutics Shares Interim Data F...
04/05/2024 16:57:57

Explore TARA-002's data in NMIBC treatment. Discover findings from three trials, including response rates, adverse events, ...

Protara Therapeutics shares are trading hi...
04/05/2024 12:10:57

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
04/05/2024 12:09:50

Protara Therapeutics Announces Oversubscri...
04/05/2024 12:05:12

Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of can...

Protara Therapeutics Announces Alignment W...
04/05/2024 12:03:48

HC Wainwright & Co. Reiterates Buy on Prot...
03/14/2024 11:14:52

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price...

Protara Therapeutics Q4 EPS $(0.90) Beats ...
03/13/2024 12:06:19

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate of ...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
03/04/2024 21:32:25

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
12/11/2023 13:06:40

Protara Therapeutics Announces Presentatio...
11/30/2023 13:37:00

New results from six patients with HGTa papillary tumors show five of six patients with HGRFS at Week 12Data continue to suppor...

Protara Therapeutics Q3 EPS $(0.87) Beats ...
11/03/2023 12:14:17

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of ...